Healthcare provider profile · identity verified

George Patrick Macris, MD

Internal Medicine · TARPON SPRINGS, FL · NPI 1336445055

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	646	187
Lisinopril	Lisinopril	278	75
Levothyroxine Sodium	Levothyroxine Sodium	274	81
Metformin Hcl	Metformin Hcl	233	67
Gabapentin	Gabapentin	180	53
Tramadol Hcl	Tramadol Hcl	177	42
Famotidine	Famotidine	170	50
Pantoprazole Sodium	Pantoprazole Sodium	161	56
Losartan Potassium	Losartan Potassium	157	46
Amlodipine Besylate	Amlodipine Besylate	152	48
Metoprolol Succinate	Metoprolol Succinate	150	45
Topiramate	Topiramate	150	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	31
Alprazolam	Alprazolam	143	31
Clonazepam	Clonazepam	140	17
Ezetimibe	Ezetimibe	134	44
Zolpidem Tartrate	Zolpidem Tartrate	130	21
Montelukast Sodium	Montelukast Sodium	128	43
Albuterol Sulfate Hfa	Albuterol Sulfate	116	55
Furosemide	Furosemide	110	39
Omeprazole	Omeprazole	107	33
Tamsulosin Hcl	Tamsulosin Hcl	103	35
Pioglitazone Hcl	Pioglitazone Hcl	92	27
Prednisone	Prednisone	86	58
Clopidogrel	Clopidogrel Bisulfate	81	23
Sertraline Hcl	Sertraline Hcl	77	25
Acetaminophen-Codeine	Acetaminophen With Codeine	76	12
Meloxicam	Meloxicam	76	32
Metformin Hcl Er	Metformin Hcl	68	26
Metoprolol Tartrate	Metoprolol Tartrate	65	22
Lorazepam	Lorazepam	62	11
Allopurinol	Allopurinol	61	20
Fluticasone Propionate	Fluticasone Propionate	59	20
Carvedilol	Carvedilol	58	21
Finasteride	Finasteride	58	17
Celecoxib	Celecoxib	56	17
Tizanidine Hcl	Tizanidine Hcl	53	24
Duloxetine Hcl	Duloxetine Hcl	48	14
Methylprednisolone	Methylprednisolone	47	37
Doxycycline Hyclate	Doxycycline Hyclate	46	37
Oxybutynin Chloride Er	Oxybutynin Chloride	46	16
Citalopram Hbr	Citalopram Hydrobromide	43	11
Donepezil Hcl	Donepezil Hcl	42	11
Glimepiride	Glimepiride	42	11
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	13
Eliquis	Apixaban	41	16
Atorvastatin Calcium	Atorvastatin Calcium	40	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	11
Alendronate Sodium	Alendronate Sodium	37	12
Estradiol	Estradiol	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Xarelto	Rivaroxaban	35	11
Baclofen	Baclofen	34	13
Azithromycin	Azithromycin	33	25
Atenolol	Atenolol	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	12
Aripiprazole	Aripiprazole	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Meclizine Hcl	Meclizine Hcl	23	12
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Temazepam	Temazepam	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Mupirocin	Mupirocin	18	11
Nifedipine Er	Nifedipine	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	11
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Azelastine Hcl	Azelastine Hcl	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Diazepam	Diazepam	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	16	12
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error